Accuray Operating Margin from 2010 to 2024
| ARAY Stock | USD 2.23 0.12 5.69% |
Check Accuray Incorporated financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Accuray Incorporated's main balance sheet or income statement drivers, such as Depreciation And Amortization of 9.5 M, Interest Expense of 8.6 M or Total Revenue of 302.7 M, as well as many indicators such as Price To Sales Ratio of 0.37, Dividend Yield of 0.0 or PTB Ratio of 1.94. Accuray financial statements analysis is a perfect complement when working with Accuray Incorporated Valuation or Volatility modules.
Accuray | Operating Margin |
Latest Accuray Incorporated's Operating Margin Growth Pattern
Below is the plot of the Operating Profit Margin of Accuray Incorporated over the last few years. It is Accuray Incorporated's Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Accuray Incorporated's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 0.04 % | 10 Years Trend |
|
Operating Profit Margin |
| Timeline |
Accuray Operating Margin Regression Statistics
| Arithmetic Mean | (0.03) | |
| Coefficient Of Variation | (214.37) | |
| Mean Deviation | 0.05 | |
| Median | (0.01) | |
| Standard Deviation | 0.08 | |
| Sample Variance | 0.01 | |
| Range | 0.2952 | |
| R-Value | 0.61 | |
| Mean Square Error | 0 | |
| R-Squared | 0.37 | |
| Significance | 0.02 | |
| Slope | 0.01 | |
| Total Sum of Squares | 0.08 |
Accuray Operating Margin History
About Accuray Incorporated Financial Statements
Accuray Incorporated investors use historical fundamental indicators, such as Accuray Incorporated's Operating Margin, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Accuray Incorporated. Please read more on our technical analysis and fundamental analysis pages.
Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the Americas, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. Accuray Incorporated was incorporated in 1990 and is headquartered in Sunnyvale, California. Accuray operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 1044 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Accuray Stock Analysis
When running Accuray Incorporated's price analysis, check to measure Accuray Incorporated's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Accuray Incorporated is operating at the current time. Most of Accuray Incorporated's value examination focuses on studying past and present price action to predict the probability of Accuray Incorporated's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Accuray Incorporated's price. Additionally, you may evaluate how the addition of Accuray Incorporated to your portfolios can decrease your overall portfolio volatility.